HOB Biotech Group Corp.,Ltd
SSE:688656.SS
126.5 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 36.804 | 47.331 | 41.651 | 86.193 | 56.618 | 63.838 | 40.154 | 21.354 | 4.335 |
| Depreciation & Amortization
| 45.173 | 39.52 | 32.526 | 24.534 | 15.398 | 13.317 | 9.638 | 7.401 | 5.494 |
| Deferred Income Tax
| 0 | 0 | -1.251 | -0.662 | 1.638 | 0.414 | -1.859 | -1.186 | 0 |
| Stock Based Compensation
| 0 | 0 | 1.251 | 0 | 0 | 0 | 3.212 | 0.958 | 2.97 |
| Change In Working Capital
| 6.782 | 3.779 | -18.767 | 2.457 | -2.818 | -10.686 | -17.114 | -17.351 | -8.789 |
| Accounts Receivables
| -2.828 | -7.834 | -0.412 | -1.318 | -13.018 | -3.823 | -8.011 | -7.791 | 0 |
| Inventory
| -0.003 | -23.415 | -19.6 | -6.257 | -2.317 | -10.469 | -10.427 | -8.53 | -15.796 |
| Accounts Payables
| 0 | 35.763 | 1.431 | 10.693 | 10.878 | 3.192 | 3.183 | 0.157 | 0 |
| Other Working Capital
| 9.614 | -0.735 | -0.184 | -0.662 | 1.638 | 0.414 | -6.687 | -8.821 | 7.007 |
| Other Non Cash Items
| 12.46 | 12.063 | 2.896 | -8.391 | -10.974 | 2.106 | 13.833 | 10.853 | 5.382 |
| Operating Cash Flow
| 101.22 | 102.693 | 58.307 | 104.793 | 58.224 | 68.575 | 46.511 | 22.258 | 6.421 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -155.366 | -178.031 | -220.207 | -167.887 | -57.011 | -34.8 | -26.658 | -20.821 | -17.155 |
| Acquisitions Net
| 0 | 0 | 0.495 | 1.375 | 1.398 | 1.048 | 1.269 | 2.712 | 0 |
| Purchases Of Investments
| -155 | -381.5 | -895.5 | -1.375 | -1.398 | 0 | 0 | 0 | -18.724 |
| Sales Maturities Of Investments
| 156.061 | 518.942 | 771.349 | 12.12 | 20.581 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.548 | 1.041 | 0 | 1.375 | 1.398 | 0 | 1.269 | 2.712 | 1.722 |
| Investing Cash Flow
| -153.756 | -39.547 | -343.863 | -154.392 | -35.032 | -33.752 | -25.39 | -18.108 | -34.156 |
| Financing Activities: | |||||||||
| Debt Repayment
| 65 | -25 | 30 | -23.957 | -6.061 | 30.992 | -17.957 | -0.554 | 13.781 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -28.17 | -20.793 | -33.421 | -18.917 | -49.194 | -47.294 | -1.656 | -1.839 | -1.528 |
| Other Financing Activities
| -26.068 | -7.328 | -6.176 | 483.92 | 0 | 5.756 | 50.972 | -1 | 14.2 |
| Financing Cash Flow
| 10.762 | -53.122 | -10.853 | 441.046 | -55.255 | -10.546 | 31.359 | -3.393 | 26.454 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.064 | 0.136 | -0.142 | -0.406 | 0.115 | -0.037 | 0.021 | 0.265 | 0.011 |
| Net Change In Cash
| -41.839 | 10.16 | -296.552 | 391.04 | -31.947 | 24.241 | 52.501 | 1.021 | -1.27 |
| Cash At End Of Period
| 121.625 | 163.464 | 153.304 | 449.855 | 58.815 | 90.762 | 66.522 | 14.02 | 12.999 |